Everest Biotech

Founded in 2000 by biochemists from the University of Oxford, Everest Biotech, a Vectors Laboratories company, specialises in the development and manufacture of anti-peptide and antigen affinity-purified goat polyclonal antibodies for biomedical research. The company applies expertise in antibody purification, proteomics and antigen design to generate reagents that enable sensitive detection of protein targets across a broad range of experimental systems. Its antibodies support applications including western blotting, immunohistochemistry, immunofluorescence, flow cytometry, ELISA and chromatin immunoprecipitation, serving research areas such as cancer biology, neuroscience, immunology, cardiovascular research, infectious disease and cell signalling.

Everest Biotech’s portfolio includes thousands of affinity-purified goat polyclonal antibodies against human, mouse and rat proteins, together with secondary antibodies, immunising peptides, positive control lysates and matched antibody pairs. The company places a strong emphasis on application-specific validation and batch consistency, with products tested across multiple analytical workflows. In addition to its catalogue products, Everest Biotech provides custom antibody development services to support specialised research requirements. Its reagents are designed for target identification, protein expression analysis, biomarker research and assay development in both basic and translational research environments.

Europa Biosite subsidiaries distribute Absolute Biotech products to researchers across Austria, Belgium, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the UK.